Reuters
18 May 2026, 11:35 UTC · 3d ago
Source · https://www.reuters.com/legal/litigation/boston-scientific-invests-15-billion-mirus-with-option-buy-heart-valve-business-2026-05-18/
Read source
Search tags
Story key points
2 claims · impact-rated
Boston Scientific invested $1.5 billion for a 34% equity stake in MiRus LLC. — A significant capital outlay indicates a strategic expansion into new technology, potentially boosting long-term growth prospects for the company.
+0.40The investment provides Boston Scientific with potential access to MiRus's heart-valve business. — Expanding the product pipeline in the high-value heart-valve segment creates a new competitive advantage and revenue stream.
+0.30Impact vectors
3 dimensions · 9 clusters
Market reaction
0 bid · 0 offered
No stock impact ranking available yet.
No stock impact ranking available yet.
Ticker attribution
Model heads
The company is expanding its heart-valve business through a strategic investment in MiRus LLC.
No ticker relationship head found.
